JC
Jamie Christensen
EVP & Chief Scientific Officer

Jamie Christensen insider trades: Mirati Therapeutics (MRTX) stock sales

EVP & Chief Scientific Officer, Mirati Therapeutics Last trade Jan 16, 2024 50 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
29
Open-market trades
since 2015
1
Company
last trade 2024

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Jamie reports to the SEC

Open-market buys and sales

29 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jan 16, 2024MRTX↓ Sell$94K
Jan 4, 2024MRTX↓ Sell$90K
Dec 18, 2023MRTX↓ Sell$137K
Sep 8, 2023MRTX↓ Sell$85K
May 24, 2023MRTX↓ Sell$28K
Jan 17, 2023MRTX↓ Sell$95K
Jan 4, 2023MRTX↓ Sell$91K
Dec 16, 2022MRTX↓ Sell$104K
Dec 2, 2022MRTX↓ Sell$156K
May 23, 2022MRTX↓ Sell$40K
Jan 18, 2022MRTX↓ Sell$76K
Jan 4, 2022MRTX↓ Sell$213K
Dec 6, 2021MRTX↓ Sell$157K
May 24, 2021MRTX↓ Sell$67K
Jan 6, 2021MRTX↓ Sell$307K
Dec 23, 2019MRTX↓ Sell10b5-1$833K
Jun 27, 2018MRTX↓ Sell$502K
Mar 9, 2018MRTX↓ Sell$726K
Feb 6, 2018MRTX↓ Sell$690K
Jan 26, 2018MRTX↓ Sell$326K
Jan 16, 2018MRTX↓ Sell$292K
Jan 11, 2018MRTX↓ Sell$338K
Nov 16, 2017MRTX↓ Sell$185K
Nov 2, 2017MRTX↓ Sell$105K
Oct 4, 2017MRTX↓ Sell$56K
Sep 15, 2017MRTX↓ Sell$9K
May 26, 2015MRTX↓ Sell$133K
Mar 5, 2015MRTX↓ Sell$152K
Feb 19, 2015MRTX↓ Sell$108K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Jamie Christensen's insider trades

Jamie Christensen is EVP & Chief Scientific Officer at Mirati Therapeutics (MRTX). Since Feb 19, 2015, Jamie has reported no open-market purchases and 29 sales worth $6.2M on SEC Form 4. There have been no open-market trades in the last 12 months.

1 sale (13% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.

Their filings also include grants and awards (18 filings), option exercises (17 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MRTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.